Project Grant HT9425261E200
Award Date 6/1/26
Completion Date 5/31/29
Dollars Obligated $905K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Aurora, CO 80045, USA
Similar Awards
- Federal Grant Award Summary The University of Colorado-Denver received a $1.18 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for a three-year performance period from June 1, 2026, through May 31, 2029. The award supports research on the use of unconventional immune cells to treat rare melanomas and understand immunotherapy resistance. This research initiative aligns with the DHA's mission to advance biomedical...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded University of Colorado-Denver a $1.4M Project Grant effective July 1, 2026, through June 30, 2029, under the Military Medical Research and Development program (CFDA 12.420). The award supports research focused on enhancing Linker for Activation of T cells (LAT) activity in chimeric antigen receptor (CAR) T cell therapies for Ewing sarcoma treatment. This research initiative represents DHA's commitment to advancing innovative...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded University of Colorado-Denver a $907,432 Project Grant effective July 1, 2026 through June 30, 2029 under the Military Medical Research and Development program (CFDA 12.420). The award supports research focused on overcoming resistance to BRAF-directed therapy in advanced thyroid cancer. This research initiative represents a translational oncology effort aligned with the DHA's mission to advance innovative medical solutions...
- The federal Project Grant award of $2,271,024.00 was provided by the Defense Health Agency, under the Military Medical Research and Development (CFDA 12.420) federal grant program, to the University of Colorado-Denver. The award, effective November 1, 2024, supports a four-year research project to improve understanding of next-generation immunotherapy responses in metastatic uveal melanoma. The University of Colorado-Denver, a major public research university with a strong focus on medical...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded University of Colorado-Denver $842,067 under the Military Medical Research and Development program (CFDA 12.420) for the project "Overcoming Resistance to BRAF-Directed Therapy in Advanced Thyroid Cancer." The award, initiated July 1, 2026, with completion targeted for June 30, 2029, supports basic and applied biomedical research designed to advance innovative medical solutions for both military service members...
- Federal Grant Award Summary The University of Colorado-Denver received a $624,000 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period of July 1, 2025, through June 30, 2027. The award supports research focused on targeting androgen receptors as a novel therapeutic strategy for advanced thyroid cancer. This research initiative aligns with the DHA's broader mission to transform healthcare for service members...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $780,000.00 to The Regents of the University of Colorado, doing business as the University of Colorado-Denver, to support research on "An Unconventional Pathway to Melanoma Development and Prevention". The research aims to investigate innovative approaches to address melanoma, a serious form of skin cancer, with the goal of improving...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded a $2.87M Project Grant to The Regents of the University of Colorado (doing business as University of Colorado-Denver) on September 1, 2025, under the Military Medical Research and Development program (CFDA 12.420). The four-year award, which extends through August 31, 2029, supports research evaluating the Clinical, Biomarkers, Imaging, and Modifiers (CBI-M) classification system for traumatic brain injury (TBI). This research...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded a $1,197,884 Project Grant to the University of California, San Diego under the Military Medical Research and Development program (CFDA 12.420) for the project titled "Mechanism Dissection and Model Development of Human PD1 in Melanoma." The award was issued on August 15, 2025, with a performance period extending through August 14, 2028. The research will be conducted at UC San Diego's La Jolla, California campus. This...
- Federal Grant Award Summary The University of Queensland received a $563,707 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2028. The award supports research to develop predictive multiomics profiling methodologies for identifying early-stage melanoma cases at elevated risk of recurrence. This research directly aligns with the DHA's mission to advance biomedical solutions...